Primecap Management Co. CA lifted its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 0.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 944,000 shares of the company’s stock after acquiring an additional 5,300 shares during the period. Primecap […]